Ben Samelson-Jones/X
Aug 4, 2025, 06:00
Genotype–Phenotype Understanding in Hemophilia B: Commentary on Factor IX Missense Variants
Ben Samelson-Jones, Assistant Professor of Pediatrics (Hematology) at the Children’s Hospital of Philadelphia, posted on X:
”As hemophilia B therapeutics become more sophisticated, there is an increased need to better understand genotype–phenotype relationships. Our in vitro studies are consistent with recent in silica approaches․”
Read the full article here.
Title: An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B”: comment from Lee et al.
Authors: Kyumin Lee, Annalisse DeSandre, Benjamin J. Samelson–Jones
Don’t miss the latest updates with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis